Seiko Diane Yamada to Tumor Burden
This is a "connection" page, showing publications Seiko Diane Yamada has written about Tumor Burden.
Connection Strength
0.023
-
Foretinib (GSK1363089), an orally available multikinase inhibitor of c-Met and VEGFR-2, blocks proliferation, induces anoikis, and impairs ovarian cancer metastasis. Clin Cancer Res. 2011 Jun 15; 17(12):4042-51.
Score: 0.023